At a glance
- Originator Orion
- Class Anti-ischaemics; Antihyperlipidaemics; Antiulcers; Catechols; Cytoprotectives; Pentanones; Small molecules
- Mechanism of Action Antioxidants; Catechol-O-methyltransferase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atherosclerosis; Peptic ulcer; Reperfusion injury